Nebenwirkungen · Reagila
Reagila 1.5 mg orodispersible tablets Reagila 3 mg orodispersible tablets Reagila 4.5 mg orodispersible tablets Reagila 6 mg orodispersible tablets · Abschnitt 4.8 · PDF-Seite 26–27
HOS-129598 · Präparat HOS-096751
26 Libido increased Erectile dysfunction Nervous Akathisia2 Sedation Tardive Seizures/ Neuroleptic system Parkinsonism3 Dizziness dyskinesia Convulsion malignant disorders Dystonia4 Dyskinesia6 Amnesia syndrome Other Dysaesthesia Aphasia extrapyramidal Lethargy diseases and abnormal movement disorders5 Eye Vision blurred Intraocular Cataract disorders pressure Photophobia increased Accommodati on disorder Visual acuity reduced Eye irritation Ear and Vertigo labyrinth disorders Cardiac Tachyarrhyth Cardiac disorders mia conduction disorders Bradyarrhyth mia Electrocardiog ram QT prolonged Electrocardiog ram T wave abnormal Vascular Hypertension Hypotension disorders Respiratory, Hiccups thoracic and mediastinal disorders Gastrointesti Vomiting Gastrooesopha Dysphagia nal Nausea geal reflux disorders Constipation disease Hepatobiliar Hepatic Blood Toxic hepatitis y disorders enzymes bilirubin increased increased
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-08T14:49:00Z · SHA-256 9d13d908e239f6368505bfcde6e4381ffb6295f6bc6de049f006e4abed967ec2 · Passage f44cdc512a4cee7cef204c39b06d3239baf4e1463e98b9312feb424461c27290 · Zeichen 2569–5252 im Abschnitt